Breast Cancer Research Review, Issue 62

In this issue:

Enobosarm in androgen receptor-positive advanced breast cancer
Prognostic value of HER2DX in early-stage HER2-positive breast cancer
Adjuvant abemaciclib + endocrine therapy in high-risk early breast cancer
Long-term PROs in monarchE
Single-agent chemotherapy in endocrine therapy-refractory metastatic invasive lobular carcinoma
Leisure-time physical activity in premenopausal breast cancer
HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancers
(Neo)adjuvant chemotherapy in endocrine therapy-treated invasive lobular breast cancer
Olaparib in real-world BRCA-mutated, HER2-negative metastatic breast cancer
Effect of diet on breast cancer recurrence
 

Please login below to download this issue (PDF)

Subscribe